Sign in
4/A

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-15-000027

Options or other derivatives

  • Director acquired 1,500,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

NIGALAYE ASHOK G · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-01-06 Conversion : show line 1 in the form Warrants −1,500,000 $0.06 $93,750 2,924,333 D
Loading xslF345X03/primary_doc.xml…